13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 25 holding rows worth $121,078,000.
- Accession
- 0001172661-17-000699
- Filer
- CIK 1534261
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 25 entries on the cover page, a total value of $121,078,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $121,078,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SAGE THERAPEUTICS INC | 78667J108 | COM | 259,500 | $13,250,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 360,000 | $11,561,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 240,500 | $10,036,000 | thousands by filing date | |
| Foundation Medicine Inc | 350465100 | COM | 546,000 | $9,664,000 | thousands by filing date | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 555,000 | $8,214,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 244,500 | $6,858,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 128,500 | $6,412,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 510,000 | $6,242,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 82,500 | $5,090,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 385,000 | $4,905,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 304,000 | $4,393,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 94,000 | $4,215,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 265,000 | $3,432,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 275,000 | $3,328,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 25,000 | $3,201,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 85,000 | $3,182,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 65,000 | $3,079,000 | thousands by filing date | |
| VERADIGM INC | 01988P108 | COMMON STOCK | 280,000 | $2,859,000 | thousands by filing date | |
| AMYRIS INC | 03236M101 | COM | 3,425,000 | $2,500,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 182,141 | $2,215,000 | thousands by filing date | |
| AEVI GENOMIC MEDICINE INC | 00835P105 | COM | 375,000 | $1,943,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 127,500 | $1,401,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 45,000 | $1,148,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 65,000 | $1,055,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 12,500 | $895,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-17-000699 | this filing | 2017-02-14 | acceptance time not in the bulk data set |